Hypofractionated Concurrent Chemoradiation in Stage III Non-small Cell Lung Cancer: Does Planning Target Volume Size Correlate With Prognosis?

Clin Oncol (R Coll Radiol). 2019 Jun;31(6):402-403. doi: 10.1016/j.clon.2019.03.002. Epub 2019 Mar 28.

Authors

M S Iqbal¹, A Greystoke², J Byrne³

Affiliations

¹ Department of Clinical Oncology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
² Department of Medical Oncology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Newcastle upon Tyne, UK.
³ Department of Radiotherapy Physics, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Newcastle upon Tyne, UK.

PMID: 30928193
DOI: 10.1016/j.clon.2019.03.002

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Chemoradiotherapy
Humans
Lung Neoplasms*
Prognosis